Hamilton Lane (NASDAQ:HLNE) Price Target Raised to $168.00 at Keefe, Bruyette & Woods

Hamilton Lane (NASDAQ:HLNEFree Report) had its price target lifted by Keefe, Bruyette & Woods from $158.00 to $168.00 in a research report released on Wednesday morning,Benzinga reports. Keefe, Bruyette & Woods currently has a market perform rating on the stock.

A number of other brokerages have also recently issued reports on HLNE. Wells Fargo & Company increased their target price on Hamilton Lane from $163.00 to $169.00 and gave the stock an “equal weight” rating in a report on Wednesday. The Goldman Sachs Group cut Hamilton Lane from a “neutral” rating to a “sell” rating and set a $139.00 target price for the company. in a report on Monday, January 6th. UBS Group raised their price target on Hamilton Lane from $150.00 to $185.00 and gave the company a “neutral” rating in a report on Tuesday, October 22nd. JPMorgan Chase & Co. boosted their price objective on Hamilton Lane from $134.00 to $175.00 and gave the stock a “neutral” rating in a research note on Thursday, November 7th. Finally, Oppenheimer upgraded Hamilton Lane from a “market perform” rating to an “outperform” rating and set a $186.00 target price for the company in a research note on Tuesday, January 21st. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $173.14.

Get Our Latest Stock Analysis on Hamilton Lane

Hamilton Lane Trading Up 0.2 %

Shares of HLNE opened at $167.19 on Wednesday. Hamilton Lane has a 1 year low of $103.42 and a 1 year high of $203.72. The company has a current ratio of 3.37, a quick ratio of 3.37 and a debt-to-equity ratio of 0.24. The stock has a 50 day simple moving average of $159.05 and a 200-day simple moving average of $162.99. The stock has a market cap of $9.27 billion, a PE ratio of 36.27 and a beta of 1.25.

Hamilton Lane (NASDAQ:HLNEGet Free Report) last issued its earnings results on Tuesday, February 4th. The company reported $1.25 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.13 by $0.12. Hamilton Lane had a return on equity of 35.59% and a net margin of 28.03%. The business had revenue of $168.26 million during the quarter, compared to analysts’ expectations of $158.86 million. During the same period in the prior year, the firm posted $0.71 EPS. Hamilton Lane’s quarterly revenue was up 34.3% compared to the same quarter last year. On average, sell-side analysts predict that Hamilton Lane will post 4.88 EPS for the current fiscal year.

Hamilton Lane Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 4th. Stockholders of record on Friday, March 14th will be given a dividend of $0.49 per share. The ex-dividend date of this dividend is Friday, March 14th. This represents a $1.96 dividend on an annualized basis and a dividend yield of 1.17%. Hamilton Lane’s payout ratio is currently 42.52%.

Institutional Investors Weigh In On Hamilton Lane

A number of institutional investors and hedge funds have recently made changes to their positions in HLNE. AQR Capital Management LLC raised its position in shares of Hamilton Lane by 3.7% during the second quarter. AQR Capital Management LLC now owns 8,979 shares of the company’s stock worth $1,110,000 after acquiring an additional 322 shares during the last quarter. The Manufacturers Life Insurance Company raised its position in shares of Hamilton Lane by 8.4% during the second quarter. The Manufacturers Life Insurance Company now owns 23,265 shares of the company’s stock worth $2,875,000 after acquiring an additional 1,810 shares during the last quarter. Truist Financial Corp raised its position in shares of Hamilton Lane by 6.8% during the second quarter. Truist Financial Corp now owns 12,477 shares of the company’s stock worth $1,542,000 after acquiring an additional 790 shares during the last quarter. Sanctuary Advisors LLC bought a new stake in shares of Hamilton Lane during the second quarter worth $824,000. Finally, Handelsbanken Fonder AB raised its position in shares of Hamilton Lane by 75.4% during the third quarter. Handelsbanken Fonder AB now owns 11,400 shares of the company’s stock worth $1,920,000 after acquiring an additional 4,900 shares during the last quarter. Institutional investors own 97.40% of the company’s stock.

Hamilton Lane Company Profile

(Get Free Report)

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.

Featured Stories

Analyst Recommendations for Hamilton Lane (NASDAQ:HLNE)

Receive News & Ratings for Hamilton Lane Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Lane and related companies with MarketBeat.com's FREE daily email newsletter.